Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share

Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.

For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• BIG3 Basketball to go public via Graf Global merger at $290 million
• Cooper Companies (COO) Reiterated at Buy by Stifel After Earnings Call